Tetra Radar · FDA Approvals · Decision date
Belite Bio Inc: FDA decision date
Belite Bio Inc (BLTE) · 12 February 2027
Food and Drug Administration (FDA) in August 2026 with Prescription Drug User Fee Act (PDUFA) target action date of February 12, 2027. ·.
Source: 6-K of 12 November 2026
The decision is pending.
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.